1 Metabolic reprogramming orchestrates CD4 T-cell immunological status and restores cardiac dysfunction in autoimmune induced-dilated cardiomyopathy mice.

2 Management of adults and children undergoing CAR t-cell therapy: best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE).

3 Challenges and limitations of primary diagnosis of T-cell and NK/T-cell lymphoma in bone marrow biopsy.

4 Metabolic Factors Contribute to T-cell Inhibition in the Ovarian Cancer Ascites.

5 Multicenter Experience with Neurally Adjusted Ventilatory Assist in Infants with Severe Bronchopulmonary Dysplasia.

6 RUNX1-mutated families show phenotype heterogeneity and a somatic mutation profile unique to germline predisposed AML.

7 Interferon-complement loop in transplant-associated thrombotic microangiopathy.

8 Phase 2 trial of montelukast for prevention of pain in sickle cell disease.

9 Treating COVID-19-Off-Label Drug Use, Compassionate Use, and Randomized Clinical Trials During Pandemics.

10 Resonant Photoacoustic Spectroscopy of NO2 with a UV-LED Based Sensor

11 Uptake of biotin by Chlamydia Spp. through the use of a bacterial transporter (BioY) and a host-cell transporter (SMVT).

12 Decreased hepatocellular carcinoma tumor burden with the achievement of hepatitis C virus sustained virologic response: unlocking the potential of T-cell-mediated immunosurveillance

13 The Human IL-23 Decoy Receptor Inhibits T-Cells Producing IL-17 by Genetically Engineered Mesenchymal Stem Cells

14 Decreased hepatocellular carcinoma tumor burden with the achievement of hepatitis C virus sustained virologic response: unlocking the potential of T-cell-mediated immunosurveillance

15 Novel Conserved-region T-cell Mosaic Vaccine With High Global HIV-1 Coverage Is Recognized by Protective Responses in Untreated Infection.

16 Characterization of T-cell responses to conserved regions of the HIV-1 proteome in BALB/c mice.

17 The soluble isoform of CTLA-4 as a regulator of T-cell responses.

18 Immunophenotype switching in cutaneous T-cell lymphoma: nature or nurture?

19 Methamphetamine functions as a novel CD4<sup>+</sup> T-cell activator via the sigma-1 receptor to enhance HIV-1 infection

20 The pipeline of antiviral T-cell therapy: what's in the clinic and undergoing development.

21 Challenges and Prospects of Chimeric Antigen Receptor T-cell Therapy for Metastatic Prostate Cancer.

22 Inhibition of Cytokine Production and Cytokine-Stimulated T-Cell Activation by FK506 (Tacrolimus)1

23 Dual T-cell Depletion with ATG and PTCy Results in Low Rates of Cytokine Release Syndrome in Peripheral Blood Haplo-HSCT.

24 Transgenic Tumor Models for Evaluating CAR T-Cell Immunotherapies.

25 Erratum: Correction to Simultaneous Diagnosis and Gene Therapy of Immuno-Rejection in Rat Allogeneic Heart Transplantation Model Using a T-Cell-Targeted Theranostic Nanosystem (ACS nano (2012) 6 12 (10646-10657))

26 Newborn Screening for Severe Combined Immunodeficiency and T-cell Lymphopenia in California, 2010-2017.

27 A structure-based rationale for sialic acid independent host-cell entry of Sosuga virus.

28 Differences for T-Cell Subtypes in Aspiration Biopsies of Patients With Kidney Transplant Under Polyclonal and Monoclonal Immunosuppressive Treatments.

29 Correction to: T-cell aging in end-stage renal disease: an evolving story with CMV (Medical Microbiology and Immunology, (2019), 208, 3-4, (281-287), 10.1007/s00430-019-00596-8)

30 Design of short peptides to block BTLA/HVEM interactions for promoting anticancer T-cell responses.

31 Evaluation of artesunate for the treatment of adult T-cell leukemia/lymphoma.

32 CD39 identifies a microenvironment-specific anti-inflammatory CD8 <sup>+</sup> T-cell population in atherosclerotic lesions

33 Association Between Impaired Vα7.2+CD161++CD8+ (MAIT) and Vα7.2+CD161-CD8+ T-Cell Populations and Gut Dysbiosis in Chronically HIV- and/or HCV-Infected Patients

34 Coarse-to-Fine Adversarial Networks and Zone-based Uncertainty Analysis for NK/T-cell Lymphoma Segmentation in CT/PET images.

35 Successful Treatment of Fanconi Anemia and T-Cell Acute Lymphoblastic Leukemia

36 Involvement of p53 acetylation in growth suppression of Cutaneous T-cell lymphomas induced by HDAC inhibition.

37 Recent Advances in Lung Cancer Immunotherapy: Input of T-Cell Epitopes Associated With Impaired Peptide Processing

38 Reconstitution of cytomegalovirus-specific T-cell immunity following unmanipulated haploidentical allogeneic hematopoietic stem cell transplantation with posttransplant cyclophosphamide.

39 Impact of immunosuppressive and antifungal drugs on PBMC- and whole blood-based flow cytometric CD154Aspergillus fumigatus specific T-cell quantification.

40 Blinatumomab for Acute Lymphoblastic Leukemia: The First Bispecific T-Cell Engager Antibody to Be Approved by the EMA for Minimal Residual Disease.

41 Forodesine in the treatment of relapsed/refractory peripheral T-cell lymphoma: an evidence-based review

42 Requirements for the generation of a Lyt-2+ T-cell proliferative response to a syngeneic tumor in the absence of L3T4+ T-cells.

43 Activated NLR family pyrin domain containing 3 (NLRP3) inflammasome in keratinocytes promotes cutaneous T-cell response in patients with vitiligo

44 Inflammatory signatures for quick diagnosis of life-threatening infection during the CAR T-cell therapy

45 Cytotoxic T-cell response to respiratory syncytial virus in mice.

46 Testosterone Inhibits Adipogenic Differentiation in 3T3-L1 Cells: Nuclear Translocation of Androgen Receptor Complex with β-Catenin and T-Cell Factor 4 May Bypass Canonical Wnt Signaling to Down-Regulate Adipogenic Transcription Factors

47 The Effects of CCR9+ and CD103+ Dendritic Cells on Regulatory T-cells in Food Allergy

48 CD45-assisted PanLeucogating for accurate, cost-effective dual-platform CD4+ T-cell enumeration

49 Testosterone inhibits adipogenic differentiation in 3T3-L1 cells: nuclear translocation of androgen receptor complex with beta-catenin and T-cell factor 4 may bypass canonical Wnt signaling to down-regulate adipogenic transcription factors

50 Establishment of an etiologic relationship between the human T-cell leukemia/lymphoma virus (HTLV) and adult T-cell leukemia

51 Cytotoxic T-cell response to respiratory syncytial virus in mice

52 pathophysiology of cd4+ t-cell depletion in hiv-1 and hiv-2 infections

53 frequency patterns of t-cell exposed motifs in immunoglobulin heavy chain peptides presented by mhcs

54 advancing car t-cell therapy for solid tumors: lessons learned from lymphoma treatment

55 fatal peripheral t-cell lymphoma presenting as hypereosinophilia and spontaneous tumor lysis syndrome: a rare case report

56 inducible t-cell co-stimulator impacts chronic graft-versus-host disease by regulating both pathogenic and regulatory t cells

57 on the effect of unit-cell parameters in predicting the elastic response of wood-plastic composites

58 corrigendum: monitoring t-cell responses in translational studies: optimization of dye-based proliferation assay for evaluation of antigen-specific responses

59 t-cell/histiocyte rich b-cell lymphoma of mass in caecum and part of ascending colon

60 rapid cloning, expression, and functional characterization of paired αβ and γδ t-cell receptor chains from single-cell analysis

61 aplicación de la citometría de flujo en el diagnóstico inmunológico de los linfomas cutáneos t application of flow cytometry in the immunological diagnosis of cutaneous t-cell lymphomas

62 death caused by possible unrecognized (too late recognized) mycobacterium gordonae infection in a patient with angioimmunoblastic t-cell lymphoma

63 selection of tumor-specific cytotoxic t lymphocytes in acute myeloid leukemia patients through the identification of t-cells capable to establish stable interactions with the leukemic cells: “doublet technology”

64 the pretreatment albumin to globulin ratio predicts survival in patients with natural killer/t-cell lymphoma

65 prediction of immunological t-cell epitopes of hepatitis c virus genotype 5a

66 the use of humoral responses as a marker of cmv burden in hiv patients on art requires consideration of t-cell recovery and persistent b-cell activation

67 evaluation of epstein-barr virus latent membrane protein 2 specific t-cell receptors driven by t-cell specific promoters using lentiviral vector

68 recruitment of bad by the chlamydia trachomatis vacuole correlates with host-cell survival.

69 leukemic phase of hepatosplenic t-cell lymphoma: a great masquerader of acute leukemia

70 beyond the antigen receptor: editing the genome of t-cells for cancer adoptive cellular therapies

71 morbidity and causes of death in patients with cutaneous t-cell lymphoma in finland

72 when aging reaches cd4+ t-cells: phenotypic and functional changes

73 study of t-cell subsets, b and nk cells in iranian patients with behcet's disease by monoclonal antibodies

74 chidamide in the treatment of peripheral t-cell lymphoma

75 stenotrophomonas maltophilia with histopathological features mimicking cutaneous gamma/delta t-cell lymphoma

76 angioimmunoblastic t-cell lymphoma: a mimic for lupus

77 human t-cell lymphotropic virus (htlv) infection in uruguay: identification of problems prevalence estimation, screening analysis and clinical management in blood donors in the 2012-2014 period

78 pseudomembranous tracheitis caused by aspergillus fumigatus in the setting of high grade t-cell lymphoma

79 the cyp2b6 g516t polymorphism influences cd4+ t-cell counts in hiv-positive patients receiving antiretroviral therapy in an ethnically diverse region of the amazon

80 cd28 blockade ex vivo induces alloantigen-specific immune tolerance but preserves t-cell pathogen reactivity

81 salt tolerance at single cell level in giant-celled characeae

82 lowering the limit: reducing the cd4 t-cell threshold for ophthalmic screening in patients with hiv in an ethnically diverse uk population

83 elevated mir-155 expression induces immunosuppression via cd39+ regulatory t-cells in sepsis patient

84 granulocytic myeloid-derived suppressor cells (gr-mdsc) in breast milk (bm); gr-mdsc accumulate in human bm and modulate t-cell and monocyte function

85 human t-cell lymphotropic virus type i (htlv-i) proviral dna viral load among asymptomatic patients and patients with htlv-i-associated myelopathy/tropical spastic paraparesis

86 case report: esophageal and gastric t-cell lymphoma: a rare entity

87 evaluation of a dry format reagent for cd4+ and cd8+ t-cell enumeration with facscount and guava polymerase chain reaction

88 dynamic perturbations of the t-cell receptor repertoire in chronic hiv infection and following antiretroviral therapy.

89 adult t-cell leukemia/lymphoma with cll-like morphology—a case report

90 peripheral t-cell lymphoma: frequency and distribution in a tertiary referral center in south india

91 extranodal natural killer/t-cell lymphoma, nasal type: a rare but critical diagnosis

92 mycobacterium tuberculosis modulates mir-106b-5p to control cathepsin s expression resulting in higher pathogen survival and poor t-cell activation

93 contribution of mesenteric lymph nodes and galt to the intestinal foxp3+ regulatory t-cell compartmentsummary

94 new insight into the pathogenesis of erythema nodosum leprosum: the role of activated memory t-cells

95 microrna181a is overexpressed in t-cell leukemia/lymphoma and related to chemoresistance

96 regulatory t-cell profile in early and late lesions of cutaneous leishmaniasis due to leishmania major

97 the immunomodulator vaca promotes immune tolerance and persistent helicobacter pylori infection through its activities on t-cells and antigen-presenting cells

98 multiple sclerosis: a disorder of altered t-cell homeostasis

99 a recipe for myositis: nuclear factor κb and nuclear factor of activated t-cells transcription factor pathways spiced up by cytokines

100 denileukin diftitox for the treatment of cutaneous t-cell lymphoma

101 gemcitabine, navelbine, and doxorubicin as treatment for patients with refractory or relapsed t-cell lymphoma

Keyword Connections

Journals

Research Groups

Bibliographies